10.01.2013 Views

Cystinosis Newsletter - Cystinosis Research Network

Cystinosis Newsletter - Cystinosis Research Network

Cystinosis Newsletter - Cystinosis Research Network

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Page 7 The <strong>Cystinosis</strong> <strong>Research</strong> <strong>Network</strong> Fall/Winter 2006<br />

<strong>Cystinosis</strong> <strong>Research</strong> Update<br />

<strong>Cystinosis</strong> <strong>Research</strong> Update<br />

By Christy Greeley, Vice President, <strong>Research</strong><br />

2006 <strong>Research</strong> Funding Announced<br />

The CRN Scientific Review Board met in July 2006 to review the studies received from this year’s call<br />

for proposals. We are proud to announce that two grants have been funded as a result of the SRB’s<br />

recommendations. They are:<br />

“Study of ATP metabolism in human cystinotic proximal tubular cells<br />

and in humans with cystinosis in vivo”<br />

Elena Levtchenko, M.D., Ph.D., University Medical Center Nijmegen,<br />

The Netherlands<br />

Grant Timeline: January 2007 – December 2007<br />

Award Amount: $68,090<br />

<strong>Cystinosis</strong> is an autosomal recessive disorder with multi-organ involvement. The disease is caused by<br />

mutations in the CTNS gene, which maps to 17p13 and encodes the lysosomal cystine carrier, cystinosin.<br />

<strong>Cystinosis</strong> initially affects the kidneys and subsequently other organs including eyes, central<br />

and peripheral nervous system, muscles, endocrine organs and liver. The aminothiol, cysteamine, depleting<br />

intralysosomal cystine, retards the deterioration of renal function and postpones the occurrence<br />

of extra-renal complications. This is in agreement with increased lysosomal cystine levels being<br />

the primary cause of this disease. However, the subsequent steps in the pathogenesis of cystinosis<br />

are unknown. Alterations of intracellular energy metabolism were postulated to be an underlying<br />

mechanism of cellular dysfunction in cystinosis based on the finding of ATP depletion in proximal tubular<br />

cells loaded with cystine dimethyl ester. However, this mechanism was neither confirmed in human<br />

renal material nor in humans with cystinosis. The study of ATP metabolism in human cystinotic<br />

proximal tubular cells and in humans with cystinosis and controls is the subject of this research proposal.<br />

The project is based on (i) our initial observations that cystinotic fibroblasts and granulocytes display a<br />

significant decrease in intracellular ATP and (ii) development of differentiated human cystinotic proximal<br />

tubular cell lines, carrying known CTNS mutations, which cystine accumulation approaches the in<br />

vivo situation.<br />

Apart from this we will evaluate intracellular ATP status in vivo in patients with cystinosis using MR<br />

spectrometry.<br />

Therefore, the current study consists of both a fundamental part and a clinical part.<br />

A. The fundamental part focuses on:<br />

The investigation of ATP homeostasis in temperature sensitive immortalized proximal tubular cell lines<br />

from cystinotic patients and healthy controls at different stages of cystine accumulation and after exposure<br />

to cysteamine.<br />

B. The clinical part focuses on:<br />

Measurement of ATP status in vivo in patients with cystinosis.<br />

The demonstration of altered ATP homeostasis in human cystinotic proximal tubular cells and in humans<br />

with cystinosis will set a major step towards better understanding the pathogenesis of the disease<br />

and ultimately to develop new therapeutic strategies in patients with cystinosis.<br />

continued on page 8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!